B型肝炎防治

Treatment and Prevention of Hepatitis B

10.6968/TJCCTM.200412.0301

陳榜(Pang Chen)

B型肝炎 ； 濕熱 ； 疫毒 ； hepatitis B ； damp heat ； epidemic toxin

中國中醫臨床醫學雜誌

10卷4期（2004 / 12 / 01）

301 - 307

繁體中文

B型肝炎在東南亞地區流行極為普遍，是引起肝癌與肝硬化的重要因素。臺灣地區自從1983年實施B型肝炎疫苗注射以後，新生代B型肝炎病毒帶原率已經受到控制，但是成人B型肝炎帶原者的比率仍非常高，目前西醫以抗病毒藥物及免疫調節劑，單獨或合併，治療B型肝炎，效果還是有限。中醫藥治療B型肝炎，不遺餘力，經過臨床經驗，得到振奮的可喜成果，相信能夠集合眾人的智慧與力量，繼續研究，終有一天，一定能將B型肝炎病毒完全消滅，以減少肝病對人類健康的威脅。

In Southeast Asia hepatitis B is extremely widespread and is a major factor in the development of liver cancer and liver cirrhosis. Since Taiwan began administering hepatitis B vaccinations in 1983 the rate of hepatitis B carriers among the younger generation has been under control, however the ratio of adults carriers remains very high. Currently western medicine employs the use of anti-viral medications and immune regulating drugs, either alone or in combination, to treat hepatitis B, although results are limited. Chinese medicine has spared no effort in its attempts to treat hepatitis B and as the result of accumulated clinical experience has achieved encouraging and fruitful results. I believe that if we can gather enough people’s knowledge and power and continue to do research, that someday we will be able to completely eradicate the hepatitis B virus, thereby diminishing the threat of liver disease to human health.